Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
ASP Isotopes Inc. Announces Pricing of $50 Million Underwritten Registered Direct Offering of Common Stock
-
Cantor Fitzgerald Reiterates Overweight Rating on NeuroPace Inc (NPCE)
-
Cantor Fitzgerald Reiterates Overweight Rating on Bicara Therapeutics Inc (BCAX)
-
Cantor Fitzgerald Reiterates Overweight Rating on Immatics (IMTX)
-
Cantor Fitzgerald Reiterates Overweight Rating on Summit Therapeutics plc (SMMT)
-
AxoGen, Inc. (AXGN) PT Lowered to $23 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Elutia (ELUT)
-
Cantor Fitzgerald Reiterates Overweight Rating on Cerus (CERS)
-
Cantor Fitzgerald Reiterates Overweight Rating on TriSalus Life Sciences, Inc. (TLSI)
-
Trump Media & Technology Group (DJT) Closes Bitcoin Treasury Deal
-
Trump Media Closes Bitcoin Treasury Deal
-
Form NPORT-P CANTOR FITZGERALD INFRAS For: Mar 31
-
Cantor Fitzgerald Reports Key Takeaways from Call With RadioMedia CEO
-
Cantor Fitzgerald reports key Takeaways from call with RadioMedia CEO
-
Cantor Fitzgerald Reiterates Neutral Rating on Marvell (MRVL)
-
Zscaler (ZS) PT Raised to $290 at Cantor Fitzgerald
-
Elastic NV. (ESTC) PT Lowered to $92 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on CrowdStrike Holdings (CRWD)
-
VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform
-
Cantor Fitzgerald Asset Management to Launch Gold Protected Bitcoin Fund
-
VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform
-
Intellia stock tumbles on safety concerns
-
Cantor Fitzgerald Reiterates Overweight Rating on MindMed (MNMD)
-
Cantor Fitzgerald Reiterates Overweight Rating on Elevance (ELV)
-
Cantor Fitzgerald Reiterates Overweight Rating on Taysha Gene Therapies (TSHA)
-
Cantor Fitzgerald Reiterates Overweight Rating on Vera Therapeutics (VERA)
-
Cantor Fitzgerald Reiterates Overweight Rating on NVIDIA (NVDA)
-
Cantor Fitzgerald Reiterates Overweight Rating on SentinelOne Inc (S)
-
Cantor Fitzgerald Reiterates Overweight Rating on Intellia Therapeutics (NTLA)
-
Cantor Fitzgerald Reiterates Overweight Rating on ORIC Pharmaceuticals (ORIC)
-
Cantor Fitzgerald on ORIC Pharmaceuticals (ORIC): 'Solid Update in Prostate Cancer for ORIC-944'
-
HTX DeepThink: Rotation Signals Emerging--Crypto Credit and InfoFi Poised as New Market Focal Points
-
Cantor Fitzgerald Reiterates Overweight Rating on NVIDIA (NVDA)
-
TITAN INTERNATIONAL, INC. TO PARTICIPATE IN JUNE CONFERENCES
-
Cantor Fitzgerald to acquire UBS hedge fund unit, expanding alternative assets
-
UBS Sells O'connor Business To Cantor Fitzgerald
-
UBS AG (UBS) Sells O'Connor to Cantor Fitzgerald
-
Cantor Fitzgerald expands asset management capabilities with acquisition of UBS’s O’Connor alternatives investment platform
-
Cantor Fitzgerald Reiterates Neutral Rating on Universal Health Services (UHS)
-
Cantor Fitzgerald Reiterates Overweight Rating on Tenet Healthcare (THC)
-
Cantor Fitzgerald Reiterates Overweight Rating on Surgery Partners (SGRY)
-
Cantor Fitzgerald Reiterates Overweight Rating on HCA Healthcare Inc (HCA)
-
Cantor Fitzgerald Reiterates Neutral Rating on Acadia Healthcare (ACHC)
-
Cantor Fitzgerald Reiterates Overweight Rating on Okta, Inc (OKTA)
-
DOMO (DOMO) PT Raised to $17 at Cantor Fitzgerald
-
DOMO (DOMO) PT Raised to Street High $17 at Cantor Fitzgerald
-
US banks tiptoe toward crypto, awaiting more green lights from regulators
-
Cantor Fitzgerald Reiterates Overweight Rating on Okta, Inc (OKTA)
-
Cantor Fitzgerald Pounding Table on NeuroPace Inc (NPCE): 'we would be buyers of NPCE on today's pullback'
-
Cantor Fitzgerald to Move 50 Alternative Investment Funds to the LODAS Transfer Agent Platform

